"Mumps Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines used to prevent infection by MUMPS VIRUS. Best known is the live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.
| Descriptor ID |
D009108
|
| MeSH Number(s) |
D20.215.894.899.488
|
| Concept/Terms |
Mumps Vaccine, Inactivated- Mumps Vaccine, Inactivated
- Vaccine, Inactivated Mumps
- Mumps Virus Vaccine, Inactivated
- Inactivated Mumps Virus Vaccine
- Inactivated Mumps Vaccine
Mumps Vaccine, Live Attenuated- Mumps Vaccine, Live Attenuated
- Mumps Virus Vaccine, Live Attenuated
- Live Attenuated Mumps Vaccine
- Live Attenuated Mumps Virus Vaccine
|
Below are MeSH descriptors whose meaning is more general than "Mumps Vaccine".
Below are MeSH descriptors whose meaning is more specific than "Mumps Vaccine".
This graph shows the total number of publications written about "Mumps Vaccine" by people in this website by year, and whether "Mumps Vaccine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2017 | 1 | 2 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Mumps Vaccine" by people in Profiles.
-
The estimated impact of decreased childhood vaccination due to COVID-19 using a dynamic transmission model of mumps in Japan. Hum Vaccin Immunother. 2021 05 04; 17(5):1313-1316.
-
Seroprevalence of mumps before the introduction of mumps-containing vaccine in Lao PDR: results from a nationwide cross-sectional population-based survey. BMC Res Notes. 2019 Mar 19; 12(1):155.
-
Immunogenicity and Safety of an F-Genotype Attenuated Mumps Vaccine in Healthy 8- to 24-Month-Old Children. J Infect Dis. 2019 01 01; 219(1):50-58.
-
Acute disseminated encephalomyelitis: complication of a vaccine preventable disease. BMJ Case Rep. 2018 Dec 27; 11(1).
-
Vaccine waning and mumps re-emergence in the United States. Sci Transl Med. 2018 03 21; 10(433).
-
Mumps epidemic in North America proves unusually stubborn. BMJ. 2017 11 15; 359:j5305.
-
An outbreak of mumps with genetic strain variation in a highly vaccinated student population in Scotland. Epidemiol Infect. 2017 11; 145(15):3219-3225.
-
Challenges in Interpretation of Diagnostic Test Results in a Mumps Outbreak in a Highly Vaccinated Population. Clin Vaccine Immunol. 2017 Feb; 24(2).
-
Immunogenicity and safety of a novel formalin-inactivated and alum-adjuvanted candidate subunit vaccine for mumps. Vaccine. 2008 Aug 05; 26(33):4276-83.